BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1063 related articles for article (PubMed ID: 24656222)

  • 1. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
    Speakman M; Kirby R; Doyle S; Ioannou C
    BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
    Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
    Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil - a therapeutic option in the management of BPH-LUTS.
    Carson CC; Rosenberg M; Kissel J; Wong DG
    Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.
    Trueman P; Hood SC; Nayak US; Mrazek MF
    BJU Int; 1999 Mar; 83(4):410-5. PubMed ID: 10210562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC; Fitzpatrick JM;
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.
    Egan KB
    Urol Clin North Am; 2016 Aug; 43(3):289-97. PubMed ID: 27476122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and partner-specific quality of life in partners of men with lower urinary tract symptoms compared with partners of men from the general population.
    Marklund H; Spångberg A; Edéll-Gustafsson U
    Scand J Urol; 2015; 49(4):321-8. PubMed ID: 25515951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
    Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
    Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study.
    Zhang W; Zhang X; Li H; Wu F; Wang H; Zhao M; Hu H; Xu K
    BMJ Open; 2019 Jun; 9(6):e022792. PubMed ID: 31221864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.
    Ertel P; Adalig B; Demircan I; Lartey B; Manyak MJ
    Int J Clin Pract; 2016 Oct; 70(10):870-880. PubMed ID: 27774780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Burden of Male Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia (BPH)-Focus on the UK.
    Kaplan SA
    J Urol; 2016 Feb; 195(2):425-6. PubMed ID: 26853000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship of socioeconomic factors with medical utilization for lower urinary tract symptoms and benign prostatic hyperplasia in a South Korean community].
    Kim HH; Kong KA; Lee HJ; Yoon H; Lee BE; Moon OR; Park H
    J Prev Med Public Health; 2006 Mar; 39(2):141-8. PubMed ID: 16615269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-the-counter medication availability could augment self-management of male lower urinary tract symptoms.
    Roehrborn CG; Miner MM; Sadovsky R
    Postgrad Med; 2018 Jun; 130(5):452-460. PubMed ID: 29932780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erectile Dysfunction and Lower Urinary Tract Symptoms.
    De Nunzio C; Roehrborn CG; Andersson KE; McVary KT
    Eur Urol Focus; 2017 Oct; 3(4-5):352-363. PubMed ID: 29191671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.